MakeMyTrip shares fall after short-seller report By Investing.com

Shares of MakeMyTrip fell 3.5% after Morpheus Research published a short-seller report alleging continued anti-competitive price-parity enforcement and accounting irregularities. The report cites a prior CCI fine of ~$26.1M (appeal with potential remaining liability including interest of up to ~$34M), a $20M receivable from insolvent Go Air only half provisioned, and a $212M cumulative difference between adjusted and IFRS profits since 2021. MakeMyTrip controls ~50% of the Indian OTA market, is valued at ~$3.5B, and faces an appeal hearing on April 29, 2026 — developments that could meaningfully pressure the stock.

Analysis

The regulatory/activist spotlight acts like an accelerant on a platform business whose economics depend on opaque commercial incentives; even absent a legal loss, partner switching and incremental compliance costs will compress take-rates and CAC dynamics over the next 6–12 months. Hotels and airlines facing scrutiny will be more likely to push for direct-booking tech and metasearch placements, creating a secular channel-shift risk that reduces the optionality of cross-sell and advertising monetization for the incumbent.

Accounting and receivable transparency are the operational levers to watch — any restatement or larger-than-expected impairment will force a re-rating through both EPS and cash-flow lenses, and could trigger covenant strain in downside scenarios. Near-term catalysts that can move the stock are audit notes, accrual changes in quarterly filings, and partner churn metrics; medium-term outcomes hinge on regulatory enforcement actions and successful appeals or settlements.

Market positioning amplifies moves: high short interest and activist narratives increase the probability of outsized intra-day volatility and episodic squeezes, but they also mean price moves can overshoot fundamentals in both directions. The contrarian axis here is binary legal outcomes versus slow erosion of commercial economics — a clean legal outcome would likely produce a sharp bounce, whereas sustained partner disengagement produces multi-quarter margin attrition.

Practical monitoring: track adjusted-to-IFRS reconciliation line items, receivable aging beyond 90/180 days, hotel room-night margin mix, and partner promotional credits; set alerts for any material changes to these KPIs in filings or partner disclosures. Those datapoints provide faster read-throughs on whether this is a transient reputational event or a structural revenue-mix reset.

Key Decisions for Investors

• Initiate a tactical short of MMYT (target 3–5% portfolio weight) with a 3–9 month horizon; position sizing calibrated to a 20% stop-loss and a primary target of 30–40% downside. Rationale: de-rating risk + potential accrual/impairment surprises; hedge with 1/2 notional in near-dated index puts to mitigate market tail-risk.
• Pair trade: short MMYT / long BKNG (dollar-neutral) for 6–12 months — size the pair to be net-zero market exposure. Expect relative alpha if partner share rotates to global OTAs; stop-loss if spread narrows by 25% from entry, target 35–50% spread capture.
• Defined-risk options: buy a 6-month MMYT put spread (long puts, short lower-strike puts) to limit downside while retaining asymmetric payoff; cost should be <4% of notional for a 30–40% downside protection band. Use as a replacement for a larger short if risk of short squeezes is a concern.
• Event-driven idea: buy exposure to Booking Holdings (BKNG) on weakness as a defensive beneficiary of any market-share flight; target 12–18% upside in 6–12 months if recovery accelerates. Hedge macro with modest long-dated index protection; trim position if key KPIs (partner churn, receivable write-offs) in MMYT prove immaterial.